Richard C. Woodman
Direktor/Vorstandsmitglied bei H3 Biomedicine, Inc.
Aktive Positionen von Richard C. Woodman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Direktor/Vorstandsmitglied | 11.01.2022 | - |
Karriereverlauf von Richard C. Woodman
Ehemalige bekannte Positionen von Richard C. Woodman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRAWS PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.11.2018 | 15.01.2021 |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 | 01.03.2018 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.01.2002 | 01.01.2006 |
| EISAI CO., LTD. | Corporate Officer/Principal | - | - |
| University of Calgary | Corporate Officer/Principal | 01.01.1990 | - |
Ausbildung von Richard C. Woodman
| University of Calgary | Doctorate Degree |
| University of British Columbia | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 3 |
| Japan | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| EISAI CO., LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
- Börse
- Insiders
- Richard C. Woodman
- Erfahrung
